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Abstract 
Exoribonucleases – among the other RNases – play a crucial role in the regulation of 
different aspects of RNA metabolism in the eukaryotic cell. To fully understand the exact 
mechanism of activity exhibited by such enzymes, it is crucial to determine their detailed 
biochemical properties, notably their substrate specificity and optimal conditions for 
enzymatic action. One of the most significant features of exoribonucleases is the direction of 
degradation of RNA substrates, which can proceed either from 5’-end to 3’-end or in the 
opposite way. Here, we present methods allowing the efficient production and purification 
of eukaryotic exoribonucleases, the preparation and labeling of various RNA substrates, and 
the biochemical characterization of exonucleolytic activity. We also explain how the 
exonucleolytic activity may be distinguished from that of endonucleases. 
 
Key words Exoribonuclease; RNase; RNA degradation; RNA; oligonucleotide labeling; 
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1. Introduction  
RNA metabolism in the eukaryotic cell is based on a wide range of enzymatic processes that 
might be considered mainly as RNA synthesis and degradation. During RNA maturation and 
decay, various steps of trimming and degradation are catalyzed by cellular enzymes called 
exoribonucleases (1, 2). RNA degradation may be initiated from the 5’-end or 3’-end and is 
dependent on the ability of the exoribonuclease to digest the substrate in a particular 
direction (1, 2). Exoribonucleases are thus either 3’ to 5’ (3’-5’) or 5’ to 3’ (5’-3’) degrading 
enzymes. Numerous representatives of each class are found in eukaryotic cells (1, 2).  
The key eukaryotic 3’-5’ exoribonucleases present both in the cytoplasm and the nucleus are 
proteins belonging to DIS3 family (3–6). Together with a 9-subunit ring-like scaffold 
regulating its nucleolytic activity, DIS3 forms a complex called the RNA exosome (6–10). This 
RNase is responsible for degradation of properly synthetized transcripts as part of general 
RNA turnover following their deadenylation (removal of poly(A) tails and associated poly(A)-
binding proteins from the 3’-end of RNA) but is also involved in quality control processes 
ensuring that various aberrant RNA molecules are eliminated from the cell (3). DIS3 also 
plays a role in RNA maturation by trimming precursors of different RNA classes to the proper 
length and also removes the RNA processing by-products (3). 
DIS3 was initially identified as a hydrolytic 3’-5’ exoribonuclease, dependent on manganese 
ions as a cofactor (11–13). Hydrolytic exonucleases utilize water molecules as nucleophiles 
when attacking the phosphodiester bond during digestion and produce nucleoside 
monophosphates as degradation products. The exoribonucleolytic activity of DIS3 was found 
to be strictly associated with a specific domain of the protein called RNB (13). 
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Recent studies carried out in independent laboratories demonstrated that DIS3 displays 
additional nucleolytic activity. Notably, another domain of DIS3, called PIN, supports 
endoribonucleolytic activity (14–16). In other words, the PIN domain of DIS3 is able to 
mediate phosphodiester bond cleavage directly at internal positions of RNA molecules. This 
endoribonucleolytic activity has requirements that differ significantly from those of the RNB-
sustained exonuclease, notably with respect to the presence of manganese ions (14, 15). 
This single discovery demonstrates the importance of defining the exact manner by which a 
given ribonuclease triggers RNA degradation. It also underscores the necessity to optimize 
experimental parameters for each individual enzyme and RNA cleavage reaction. 
The major eukaryotic exoribonuclease working in the direction opposite to DIS3 is XRN1 (17). 
This cytoplasmic 5’-3’ hydrolytic RNase is involved in mRNA decay as well as in the 
degradation of RNA molecules arising from endonucleolytic cleavage events. A notable 
characteristic of XRN1 is its strong preference for RNA substrates with monophosphorylated 
5’-ends. In other words, XRN1 is a 5’-3’ exonuclease sensitive to the 5’-end phosphorylation 
status (18). This explains why removing the cap structure from mRNA 5’-ends (de-capping) is 
a prerequisite for XRN1 activity in vivo (19). In vitro, the presence of a triphosphate, hydroxyl 
group, or cap structure at the 5’-end of the RNA substrate prevents or at least significantly 
diminishes XRN1 activity (20).  
To assess if a protein is an exoribonuclease, a simple assay based on incubation with an 
internally labeled RNA substrate (obtained by in vitro transcription in the presence of a 
radioactive NTP) and analysis of the products by thin layer chromatography (TLC) may be 
used. Release of NMP is then an indication of hydrolytic exonuclease activity (21, see Fig. 1c 
therein). However, to determine the directionality of RNA degradation by an 
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exoribonuclease and to distinguish its biochemical properties from those of endonucleolytic 
enzymes, more complex activity assays (with differentially labeled RNA oligonucleotide 
substrates) are required. In principle, three types of RNA substrates need to be probed in 
such assays: linear substrates with a radioactive or fluorescent label at the 5’- or 3’-end and 
circular RNA substrate (Fig. 1). [Note to publisher: Figure 1 near here]. 
The type of nuclease activity supported by a given protein is deduced from the nature 
of labeled RNA products obtained in the assays. If an enzyme generates nucleoside 
monophosphate from 5’-end labeled RNA as well as fragment(s) of several nucleotides (or a 
ladder of degradation products) from a 3’-end labeled substrate, then it is a 5’-3’ 
exoribonuclease (Fig. 1a). A 3’-5’ exoribonuclease should in turn generate nucleoside 
monophosphate from a 3’-end labeled RNA substrate and RNA fragment(s) (or ladder) from 
a 5’-end labeled substrate (Fig. 1b). A feature allowing to unambiguously discriminate 
between endo- and exoribonucleolytic activity is an inability of the latter (irrespective of the 
direction in which RNA degradation is carried out) to act on circular RNA substrates (Fig. 
1a,b). By contrast, endoribonucleases can cleave and linearize circularized substrates (Fig. 
1c,d). With end-labeled linear substrates, endoribonucleases will generate RNA fragments of 
defined lengths if they are using a specific cleavage site (“processing” endonucleases) (Fig. 
1c) or ladders of decay products if they do not have clear substrate specificity (“degradative” 
endonucleases) (Fig. 1d). These various patterns of RNA degradation are usually determined 
upon analysis by denaturing polyacrylamide gel electrophoresis (PAGE) and by a gel imaging 
method compatible with the RNA labels (i.e., radioactive or fluorescent). 
 One characteristic of exoribonucleases is their degree of processivity, from purely 
processive to distributive enzymes. Distributive exonucleases release their RNA substrate 
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following each removal of a nucleotide from the molecule extremity and must rebind RNA 
prior to each new cycle of catalysis. Such nibbling activity is usually manifested on a PAGE gel 
by RNA degradation ladders (below the full-length RNA band) resulting from the formation 
of multiple digestion products, each differing from the next by only one nucleotide. By 
contrast, processive exonucleases digest RNA substrates in a continuous manner, without 
releasing them between consecutive rounds of catalysis. This is reflected by the fast 
appearance of the final, short degradation product in the time course of the reaction. In the 
extreme case of a highly-processive exonuclease and if there is no structural constraint 
within RNA (which may impair degradation), the only detectable products may be 
mononucleotides irrespective of whether 5’-end or 3’-end labeled RNA molecules are used 
(Fig. 1a,b). In this case, determination of directionality requires a RNA substrate containing 
an asymmetrically-positioned component able to inhibit  the progression of the 
exoribonuclease (Fig. 1e) (22). Mononucleotides will be detected only if the label is present 
at one extremity of the RNA molecule while degradation of substrates labeled at the 
opposite end will give rise to the appearance of a detectable degradation intermediate (Fig. 
1e) (22). The length of the intermediate is dependent on the site of modification and thus 
provides an unequivocal solution to the puzzle of whether the exoribonuclease digests RNA 
substrates in the 5’-3’ or 3’-5’ direction. 
In vitro examination of the biochemical properties of a particular exoribonuclease is 
an essential part of the characterization of the enzyme and often helps in better 
understanding of the role played by the exonuclease of interest in vivo. The methods 
described herein provide a complete tutorial allowing the comprehensive investigation of 
the enzymatic activity of eukaryotic exoribonucleases, which was tested and proved to be 
successful in multiple cases in our laboratory. Although these methods are directly relevant 
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to the analysis of hydrolytic enzymes, they may be relatively easily adapted to 
phosphorolytic exonucleases, such as polyribonucleotide phosphorylase (PNPase), which 
utilizes orthophosphate instead of water during nucleophilic attack at the phosphodiester 
bond in RNA and produces nucleoside diphosphates as the reaction products. In such case, 
inorganic phosphate must be present in the reaction buffers. 
We begin this chapter with methods for cloning an exonuclease coding sequence into 
a plasmid vector enabling the expression of the protein fused to 6xHis-SUMOTag at its N-
terminus (section 3.1) and construction of its variant for expression of the catalytic mutant 
(section 3.2), which serves as an essential negative control in RNase activity assays. Next, we 
present methods for the production (section 3.3) and purification (section 3.4) of 
recombinant exonucleases using the 6xHis-SUMOTag. A preliminary activity assay employing 
uniformly labeled transcript and TLC analysis is then described (section 3.5). Subsequent 
sections are dedicated to the description of the methods allowing purification of RNA 
oligonucleotides (section 3.6) and preparation of substrates labeled in different ways 
(section 3.7). Finally, we describe the procedures for gel-based assays of exoribonucleolytic 
activity (section 3.8), including one allowing study of the impact of 5’-end phosphorylation 
status on 5’-3’ exoribonuclease activity (section 3.9). Two main eukaryotic exoribonucleases 
mentioned earlier, namely DIS3 and XRN1, were used in the experiments illustrating the 
methods presented in this chapter.  
 
2. Materials 
2.1. Preparation of the expression vector coding for the exonuclease of interest with an N-
terminal 6xHis-SUMOTag 
 
 
8 
 
1. A construct encompassing the exonuclease coding sequence (see Note 1), to be used as a 
template for amplification of the insert comprising the exonuclease open reading frame. 
2. 200 µL PCR microtubes. 
3. Phusion High Fidelity DNA Polymerase with 5x Phusion HF buffer and 100% DMSO 
(Thermo Scientific). 
4. 10 mM dATP, dGTP, dCTP, and dTTP stocks or 10 mM dNTP mix (see Note 2). Store at -
20oC as 50 µL aliquots. 
5. SLIC-F (forward) primer: 5’-TGATTGAAGTCTACCAGGAACAAACCGGTggatccATGN17-22-3’; 
nucleotides in italics are complementary to the pET28M-6xHis-SUMOTag vector; BamHI 
site is bolded; underlined triplet represents translation initiation codon; N17-22 
corresponds to the nucleotides complementary to the insert, directly following ATG 
triplet. 
6. SLIC-R (reverse) primer: 5’-CGGATCTCAGTGGTGGTGGTGGTGGTGctcgagTTAX17-22-3’; 
nucleotides in italics are complementary to the pET28M-6xHis-SUMOTag vector; XhoI 
site is bolded; underlined triplet represents translation termination codon; X17-22 
corresponds to the nucleotides complementary to the insert, directly preceding STOP 
codon and should be in reverse complement. 
7. Sterile water. 
8. Thermocycler. 
9. 1% agarose gels containing 1x TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.3) or 1x TBE 
(89 mM Tris-borate, 1 mM EDTA, pH 8.3).  
10. 40000x Ethidium bromide stock at 10 mg/mL in water. 
11. DNA molecular weight marker. 
12. UV transilluminator coupled with a camera. 
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13. Refrigerated centrifuge.  
14. (25/24/1) Phenol/chloroform/isoamyl alcohol (v/v/v) mix (see Note 3). 
15. Chloroform. 
16. 3 M sodium acetate (NaOAc), pH 5.2. 
17. 96% (v/v) and 75% (v/v) ethanol. 
18. 6x Orange G loading solution: 10 mM Tris-HCl pH 7.6, 0.15% (w/v) Orange G, 60% (v/v) 
glycerol, 60 mM EDTA. 
19. 10000x GelGreenTM (Biotium) stock in water. 
20. UV/vis transilluminator (e.g., Dark Reader blue light transilluminator from Clare Chemical 
Research). 
21. Sterile scalpel blades. 
22. Commercial gel extraction kit (e.g., QIAquick Gel Extraction Kit from Qiagen). 
23. Thermoblock. 
24. pET28M-6xHis-SUMOTag plasmid vector. 
25. BamHI and XhoI restriction endonucleases with supplied buffer. 
26. 20 mg/mL BSA. 
27. 3 U/µL T4 DNA polymerase. 
28. Chemo-competent E. coli MH1 strain (araD lacX74 galU hsdR hsdM rpsL). 
29. SOB (Super Optimal Broth) liquid medium: 2% bacto-tryptone, 0.5% bacto-yeast extract, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4. 
30. LB-agar plates containing 50 µg/mL of kanamycin.  
31. Standard LB growth medium supplemented with 50 µg/mL of kanamycin. 
32. Incubation shaker. 
33. Commercial, column-based kit for small-scale plasmid purification from bacterial cells. 
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34. Set of primers for sequencing of the insert cloned into pET28-6xHis-SUMOTag (unique 
for a given insert). 
 
2.2 Construction of the expression vector encoding the exonuclease with an inactivating 
mutation in the catalytic site 
1. MUT-F (forward) and MUT-R (reverse) primers to be used during site-directed 
mutagenesis (see Note 4). 
2. Sterile water. 
3. F-dye (formamide loading dye): 90% deionized formamide in 1x TBE buffer, 0.03% (w/v) 
xylene cyanol, 0.03% (w/v) bromophenol blue, 20 mM EDTA. 
4. Thermoblock. 
5. 20% denaturing acrylamide stock:  20 % acrylamide:bisacrylamide (19:1) and 8 M urea in 
1x TBE buffer. Filter with a 0.2 µm (pore size) filter unit and store at 20oC in a glass bottle 
wrapped with aluminum foil to protect from light (see Note 5). 
6. “0% acrylamide” solution: 8 M urea in 1x TBE. Filter with a 0.2 µm (pore size) filter unit. 
7. 10% denaturing polyacrylamide gel (20 cm x 20 cm): a short time before use, mix 25 mL 
of 20% denaturing polyacrylamide stock with 25 mL of “0% acrylamide” solution, 300 µL 
of 10% ammonium persulfate (APS), and 30 µL of N,N,N’,N’-tetramethylethylenediamine 
(TEMED)  (see Note 6). Pour mixture into gel plates equipped with 1 mm-thick spacers, 
make sure to avoid air bubbles, and insert the appropriate comb (see Notes 7 and  8). 
Wait for approximately 30 minutes until polymerization is complete. 
8. Vertical gel electrophoresis system with power supply. 
9. Saran film. 
10. Hand-held UV lamp. 
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11. Sterile scalpel blades. 
12. Laboratory burner or lighter. 
13. Refrigerated centrifuge. 
14. Liquid nitrogen (in a styrofoam box or in a thermos). 
15. Forceps. 
16. DNA elution buffer: 1 M ammonium acetate, 1 mM EDTA, 0.1% SDS. 
17. 2-propanol. 
18. Microvolume spectrophotometer (e.g., NanoDrop 2000 from Thermo Scientific). 
19. Phusion High Fidelity DNA Polymerase with 5x Phusion HF buffer and 100% DMSO 
(Thermo Scientific). 
20. 10 mM dNTP Mix (see Note 2). 
21. Thermocycler. 
22. 1% agarose gels containing 1x TAE or 1x TBE. 
23. DpnI restriction endonuclease. 
24. Chemo-competent MH1 strain (see section 2.1). 
25. SOB medium, LB medium and LB-agar plates as in section 2.1. 
26. Incubation shaker. 
27. Restriction endonuclease recognizing the site introduced into the MUT-F/MUT-R primers 
(see Note 4). 
28. Set of primers for sequencing of the insert cloned into pET28-6xHis-SUMOTag (unique 
for a given insert). 
 
2.3 Heterologous expression of the exonuclease in bacteria 
1. Chemo-competent E. coli BL21-CodonPlus-RIL strain (Stratagene) (see Note 9). 
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2. LB-agar plates as in section 2.1 
3. Standard, sterile LB medium supplemented with 50 µg/mL of kanamycin and 34 µg/mL of 
chloramphenicol. 
4. 100 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) prepared right before use by 
dissolving 0.24 g of IPTG in 10 mL of sterile water. 
5. Incubation shaker. 
6. Refrigerated centrifuge. 
 
2.4 Purification of 6xHis-SUMO-tagged exonuclease 
1. Lysis buffer: 20 mM Tris-HCl pH 8, 200 mM NaCl, 10 mM imidazole, 10 mM 2-
mercaptoethanol, 1 mM PMSF, 2 μM pepstatin A, 0.6 μM leupeptin, 2 mM benzamidine, 
2 μg/mL chymostatin.  
2. Sonicator (e.g., Bioruptor® XL sonicator from Diagenode) with accessories (see Note 10). 
3. Ultracentrifuge. 
4. 1 mL Ni-NTA Superflow Cartridge column (Qiagen). 
5. Automated, FPLC-type chromatography system. 
6. Standard 96-well plates. 
7. Buffer A: 20 mM Tris-HCl pH 8, 200 mM NaCl, 10 mM imidazole, 10 mM 2-
mercaptoethanol. 
8. Buffer B: 20 mM Tris-HCl pH 8, 1 M NaCl, 10 mM imidazole, 10 mM 2-mercaptoethanol. 
9. Buffer C: 20 mM Tris-HCl pH 8, 200 mM NaCl, 600 mM imidazole, 10 mM 2-
mercaptoethanol. 
10. Buffer D: 20 mM Tris-HCl pH 8, 1 M NaCl, 600 mM imidazole, 10 mM 2-mercaptoethanol. 
11. SUMO protease. 
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12. Dialysis tubing with a proper molecular weight cut-off. 
13. Precast 10-12% SDS-PAGE gels with adequate electrophoresis system and power supply. 
14. Staining solution for SDS-PAGE gels: 0.025% (w/v) Coomassie Brilliant Blue R-250, 7.5% 
(v/v) acetic acid, 40% (v/v) methanol. 
15. De-staining solution for SDS-PAGE gels: 4% (v/v) acetic acid, 10% (v/v)methanol or 
ethanol. 
16. SuperdexTM 75 100/300 GL or SuperdexTM 200 10/300 GL size exclusion column (GE 
Healthcare). 
17. GF buffer: 10 mM Tris-HCl pH 8, 150 mM NaCl. 
18. RNase-free  glycerol. 
19. Liquid nitrogen.  
 
2.5 Preliminary analysis of exoribonucleolytic activity 
1. Linearized, gel-purified plasmid DNA template (see Note 11). 
2. 10x RNAPol Reaction Buffer (New England Biolabs). 
3. 100 mM DTT. 
4. NTP Mix: 2.5 mM ATP, 2.5 mM GTP, 2.5 mM CTP, and 0.25 mM UTP in RNase-free water. 
5. RiboLockTM RNase Inhibitor (Thermo Scientific). 
6. 3000 Ci/mmol [α-32P]-UTP. 
7. T7 (or SP6) RNA polymerase (see Note 11). 
8. 1/1 (v/v) Phenol/chloroform mix. 
9. SephacrylTM S-200 solution (GE Healthcare). 
10. Spin modules with catch tubes (MP Biomedicals). 
11. TE buffer: 10 mM Tris-HCl pH 8, 1 mM EDTA. 
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12. Hand-held radioactivity detector. 
13. RNA dilution buffer: 10 mM Tris-HCl pH 8, 20 mM KCl. 
14. 0.5 M EDTA, pH 8.0. 
15. Exonuclease reaction buffer: 10 mM Tris-HCl pH 8, 90 mM NaCl, 170 µM MgCl2, 2 mM 2-
mercaptoethanol (see Note 12). 
16. Liquid nitrogen (in a styrofoam box or in a thermos). 
17. TLC PEI Cellulose plates 20 x 20 cm. Cut the plate into two parts (20 x 10 cm) and, using a 
thin line marker, draw a line parallel to the longer (20 cm) edge of the plate (at a 
distance of approximately 1.5 cm from the edge), on its glossy side, not covered with PEI 
Cellulose matrix. Using the marker, draw reasonably large dots along the line, separated 
by at least 0.75 cm distance from each other. The line with dots should be visible from 
the other side (through the plate). 
18. TLC developing solution: 1 M formic acid, 0.5 M LiCl. 
19. A tray to be filled with TLC developing solution or a chromatography chamber. 
20. Phosphorimager (e.g., FLA-3000 imager from Fuji) with phosphorimaging plates and 
cassettes. 
 
2.6 Purification of the synthetic RNA oligonucleotide substrate 
1. Materials 2-15 from section 2.2. 
2. RNA elution buffer: 100 mM Tris-HCl pH 7.5, 150 mM NaCl, 12.5 mM EDTA, 1% SDS. 
3. 1/1 (v/v) Phenol/chloroform mix. 
4. Rotating wheel. 
5. 2-propanol 
6. Microvolume spectrophotometer. 
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2.7 5’-end labeling of synthetic RNA oligonucleotides 
1. 150 pmol/µL, PAGE-purifed RNA oligonucleotide in sterile RNase-free water. 
2. T4 polynucleotide kinase (PNK) enzyme with 10x PNK reaction buffer. 
3. 3000 Ci/mmol [γ-32P]-ATP. 
4. Sterile RNase-free water. 
 
2.8 3’-end labeling of synthetic RNA oligonucleotides 
1. 150 pmol/µL, PAGE-purifed RNA oligonucleotide in sterile RNase-free water. 
2. 3.75 mM Cytidine-3’-monophosphate (3’-CMP) in sterile RNase-free water. 
3. T4 polynucleotide kinase (PNK) enzyme with 10x PNK reaction buffer. 
4. 3000 Ci/mmol [γ-32P]-ATP. 
5. 1/1 (v/v) Phenol/chloroform mix. 
6. 100% DMSO.  
7. 1 mM ATP.  
8. 100 mM DTT.  
9. RiboLockTM RNase Inhibitor (Thermo Scientific; 40 U/µL) or equivalent.  
10. T4 RNA ligase I with 10x ligase reaction buffer. 
 
2.9 Preparation of labeled circular RNA oligonucleotide 
1. 150 pmol/µL, PAGE-purifed RNA oligonucleotide in sterile RNase-free water. 
2. Sterile RNase-free water.  
3. 500 mM Tris-HCl pH 8.0. 
4. 50 mM MgCl2.  
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5. 100 mM DTT. 
6. 100 µM ATP.  
7. 3000 Ci/mmol [γ-32P]-ATP. 
8. 40 U/µL RiboLockTM RNase Inhibitor (Thermo Scientific).  
9. T4 PNK enzyme and 10x reaction buffer. 
10. T4 RNA ligase I and 10x reaction buffer. 
 
2.10 Preparation of double-stranded RNA substrate 
1. 150 pmol/µL, PAGE-purifed RNA oligonucleotide 1 in sterile, RNase-free water (see Note 
13). 
2. 150 pmol/µL, PAGE-purifed complementary RNA oligonucleotide 2 in sterile, RNase-free 
water (see Note 14). 
3. 5’-labeled RNA oligonucleotide 1, prepared as described in section 3.7.1. 
4. RNA dilution buffer: 10 mM Tris-HCl pH 8, 20 mM KCl. 
5. 15% native polyacrylamide stock – acrylamide:bisacrylamide (19:1) in 1x TBE buffer (see 
Note 5). Filter with a 0.2 filter unit and store at 20oC in a glass bottle wrapped with 
aluminum foil to protect from light. 
6. 15% native polyacrylamide gel (10 cm x 8 cm) prepared from 15% native polyacrylamide 
stock with 1 mm thick spacers and 0.3 cm-teeth comb as described in section 2.2. 
7. Vertical gel electrophoresis system.  
8. Native gel loading dye: 10 mM Tris-HCl pH 8.0, 60% (v/v) glycerol, 60 mM EDTA, 0.03% 
(w/v) bromophenol blue, 0.03% (w/v) xylene cyanol. 
9. Phosphorimager with phosphorimaging plates and cassettes. 
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2.11 Purification of labeled RNA oligonucleotides 
1. 1/1 (v/v) Phenol/chloroform mix. 
2. Materials 2-9 and 11-15 from section 2.2. 
3. Autoradiography film (such as Kodak BioMax or equivalent). 
4. RNA elution buffer (see section 2.6). 
5. 2-propanol. 
6. 20 mg/mL RNase-free glycogen. 
7. Hand-held radioactivity detector. 
8. 10% denaturing polyacrylamide gel (10 cm x 8 cm) prepared with 1 mm thick spacers and 
0.3 cm-teeth comb as described in section 2.2. 
9. Vertical gel electrophoresis system. 
10. Phosphorimager with phosphorimaging plates and cassettes. 
 
2.12 Gel-based exoribonuclease activity assay with 5’-labeled RNA substrate 
1. 20% denaturing polyacrylamide gel prepared with 1 mm thick spacers and 0.3 cm-teeth 
comb as described in section 2.2 (see Note 15). 
2. Vertical gel electrophoresis system. 
3. F-dye (see section 2.2). 
4. Exonuclease reaction buffer: 10 mM Tris-HCl pH 8.0, 90 mM NaCl, 170 µM MgCl2, 2 mM 
2-mercaptoethanol (see Note 12). 
5. Liquid nitrogen (in a styrofoam box or in a thermos). 
6. 1x TBE buffer. 
7. Saran. 
8. Phosphorimager with phosphorimaging plates and cassettes. 
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2.13. XRN1 5’-3’ exoribonuclease activity assay with RNA substrates having different 5’-
end phosphorylation status and 3’-end fluorescent labels 
1. 200 µM stocks of synthetic RNA oligonucleotide 
5’ACUCACUCACUCACCAAAAAAAAAAAAACC (see Note 16) containing, at the 5’-terminus, 
a monophosphate (5’-P), triphosphate (5’-PPP), hydroxyl group (5’-OH) or methylated 
cap (5’-m7Gppp) and labeled with fluorescein amidite (FAM) at the 3’-end. Each 
oligonucleotide batch is purified by RNase-free dual HPLC and PAGE (see Note 17).  
2. Sterile RNase-free water. 
3. 1 U/µL XRN1 (New England Biolabs). 
4. 20% denaturing polyacrylamide gel prepared with 1 mm thick spacers and 0.25 cm-teeth 
comb as described in section 2.2  (see Note 18). 
5. Vertical gel electrophoresis system. 
6. F-dye (see section 2.2). 
7. 10x NEBuffer 3 (New England Biolabs). 
8. 40 U/µL RiboLockTM RNase Inhibitor (Thermo Scientific). 
9. Liquid nitrogen (in a styrofoam box or in a thermos). 
10. 1x TBE buffer. 
11. High-voltage DC power supply. 
12. Saran. 
13. Phosphorimager with fluorescence detection capability (e.g., TyphoonTM FLA-9000 
biomolecular imager from GE Healthcare). 
 
3. Methods 
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3.1. Preparation of the expression vector coding for the exonuclease of interest with an N-
terminal 6xHis-SUMOTag 
There are various ways to prepare a plasmid construct bearing the coding sequence of an 
exonuclease in a way allowing its efficient heterologous expression in bacteria and its 
purification in a soluble form, which is a prerequisite for successful biochemical in vitro 
assays. In our laboratory, we routinely use a derivative of pET28a plasmid with SUMOTag 
(pET28M-6xHis-SUMOTag). We utilize the sequence and ligation independent cloning (SLIC) 
procedure to introduce the open reading frame corresponding to the protein of interest in 
frame with the N-terminal 6xHis-SUMOTag. In our hands SLIC works much more efficiently 
than standard cloning strategies. Besides, the linearized acceptor plasmid may be employed 
for various inserts without the need of fresh preparation before each cloning attempt. 
Furthermore, we have found that the N-terminal 6xHis-SUMOTag significantly increases the 
solubility of numerous proteins, including exonucleases, such as DIS3 protein homologs from 
different species. Below we present our protocol for SLIC. 
 
3.1.1 Preparation of the insert 
1. Amplify the sequence coding for the exonuclease of interest using the SLIC-F and SLIC-R 
pair of oligonucleotides and a DNA polymerase with a high fidelity rate such as Phusion 
to avoid mutations. Mix 10 µL of 5x Phusion HF buffer, 1.5 µL of DMSO, 1 µL of 10 mM 
dNTP mix, 1 µL of the SLIC-F primer (5 pmol/µL), 1 µL of  the SLIC-R primer (5 pmol/µL), 
100 ng of the plasmid containing the DNA fragment encompassing the open reading 
frame coding for the exonuclease of interest (see Note 1), 0.5 µL of the Phusion High-
Fidelity DNA Polymerase (2 U/µL), and sterile water to 50 µL. To increase the amount of 
insert, prepare several (4-6) identical reaction mixtures from a master mix. 
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2. Place the mixtures in a thermocycler and run the following PCR program (see Note 19): 
98oC for 3 min (initial denaturation) followed by 35 cycles of denaturation at 98oC for 10 
s, hybridization at 55oC for 30 s, and elongation at 72oC for 30 s per kilobase of insert (see 
Note 20) and by a final elongation step at 72°C for 10 min. 
3. Combine mixtures in one 1.5 mL microtube and use 5 µL to check size of the PCR 
products on a standard 1% agarose gel followed by ethidium bromide staining (see Note 
21). 
4. Extract the remainder of the PCR mixture with an equal volume of 
phenol/chloroform/isoamyl alcohol. Centrifuge at 21000 x g for 5 min at room 
temperature. 
5. Transfer the upper aqueous phase to a new 1.5 mL microtube and extract with one 
volume of chloroform; Centrifuge at 21000 x g for 5 min at room temperature. 
6. Transfer the upper aqueous phase to a new 1.5 mL microtube, add 0.1 volume of 3 M 
sodium acetate (pH 5.2) and precipitate DNA with 2.5 volumes of 96% ethanol. 
Centrifuge at 21000 x g for 5 min at 4°C. Discard supernatant. 
7. Wash the pellet with 1 mL of 75% ethanol and centrifuge at 21000 x g for 5 min at 4°C. 
8. Remove supernatant and leave the tube opened for 5 min at room temperature to air-
dry the pellet (see Note 22). 
9. Suspend the pellet in 40 µL of sterile water. 
10. Add 8 µL of the 6x Orange G loading dye to the concentrated PCR products and load 12 
µL of the mixture into each of four wells of a 1% agarose gel containing GelGreenTM (see 
Note 23). 
11. After electrophoresis for 1 h at 7 V/cm, place the gel on a transilluminator and excise the 
appropriate bands with a sterile scalpel. Use a commercial, spin column-based gel 
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extraction kit to recover DNA, following manufacturer’s instructions. About 35 µL of DNA 
sample should be recovered at this stage. 
12. Use ~3 µL of sample to check the purity and estimate the concentration of purified insert 
by standard 1% agarose gel electrophoresis using known quantities of molecular weight 
marker as reference (see Note 24). 
 
3.1.2 Preparation of the vector 
1. Digest approximately 4 µg of pET28M-6xHis-SUMOTag vector with the BamHI and XhoI 
enzymes in a total volume of 20 µL, following the recommendations of the manufacturer 
of the enzymes. 
2. Adjust the volume to 200 µL with sterile water and extract with one volume of 
phenol/chloroform/isoamyl alcohol. Centrifuge at 21000 x g for 5 min at room 
temperature. 
3. Phenol-extract and ethanol-precipitate the mixture as described in section 3.1.1, steps 
4–8. Resuspend the DNA pellet in 20 µL of sterile water. 
4. Add 4 µL of the 6x Orange G loading dye to the concentrated linearized vector and load 6 
µL of the mixture into each of four wells of a preparative 1% agarose gel containing 
GelGreenTM (see Note 23). 
5. After electrophoresis for 1 h at 7 V/cm, place the gel on a transilluminator and excise the 
appropriate bands with a sterile scalpel. Use a commercial, spin column-based gel 
extraction kit to recover DNA, following manufacturer’s instructions. Eventually, elute 
DNA from the column using 20 µL of sterile water pre-warmed to 70oC. 
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6. Use ~3 µL of sample to check the purity and estimate the concentration of purified 
linearized vector by standard 1% agarose gel electrophoresis using known quantities of 
molecular weight marker as reference (see Note 24). 
 
3.1.3 SLIC reaction 
1. Mix 17.5 µL of purified insert (section 3.1.1, step 11), 2 µL of NEBuffer 2, 0.3 µL of BSA, 
and 0.2 µL of T4 DNA polymerase and incubate for 30 minutes at 22oC. Then, add 2 µL of 
any 10 mM dNTP (for instance, dGTP) and place on ice. 
2. In another microtube, mix 100 ng of linearized vector (section 3.1.2, step 5), 1.5 µL of 
NEBuffer 2, 0.3 µL of BSA, 0.2 µL of T4 DNA polymerase, and sterile water to 15 µL and 
incubate for 30 minutes at 22oC. Then, add 1.5 µL of any 10 mM dNTP (for instance, 
dGTP) and place on ice. 
3. Combine both insert and vector mixtures and incubate for 7 min at 44oC in a 
thermoblock. Then, switch off heating and wait until the device cools down to room 
temperature (see Note 25). Place the tube on ice (see Note 26). 
 
3.1.4 Transformation of bacteria with SLIC products and selection of transformants 
1. Transform an aliquot of chemo-competent MH1 cells (see Note 27) with 20 μL of the SLIC 
products. Place the tube containing the mixture of bacteria and DNA on ice for 30 
minutes, incubate it for exactly 90 seconds at 42oC in a thermoblock, and immediately 
add 1 mL of SOB medium. Incubate with shaking at 37oC for 60 minutes to express 
kanamycin resistance. Streak on LB-kanamycin plates and incubate  overnight at 37oC. 
2. Pick several (6-10) colonies with sterile toothpicks and use each of them to inoculate 5 mL 
of LB medium supplemented with kanamycin. Incubate overnight at 37oC with shaking. 
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3. Use 3 mL of each bacterial culture to isolate plasmids using a commercial mini-
preparation kit or other method of choice. 
4. Digest the purified plasmids with BamHI and XhoI enzymes following manufacturer’s 
instructions. Analyze the digestion products by standard 1% agarose gel electrophoresis 
to validate the presence of the properly-sized insert. 
5. Verify insert sequence in selected plasmid(s) using a commercial sequencing service or 
core facility. Make sure that unwanted mutations are absent. 
 
3.2 Construction of the expression vector encoding the exonuclease with an inactivating 
mutation in the catalytic site 
Bacterial cells used for heterologous expression of eukaryotic exonucleases also contain 
ribonucleases, which may co-purify with the protein of interest and interfere with correct 
interpretation of the subsequent biochemical assays. Thus, it is absolutely necessary to have 
a proper negative control. Bacteria transformed with an empty expression vector may be 
used at initial stage of analysis. However, it is strongly advisable to prepare a vector 
expressing an active site mutant of the exonuclease under study, provided that the mutation 
abolishes the exoribonucleolytic activity of the protein. To this end, one should use all 
structural and mechanistic information available to determine which residue(s) is the best 
target(s) for site-directed mutagenesis.  
 
3.2.1 Purification of primers for site-directed mutagenesis 
To achieve a high efficiency of mutagenesis it is absolutely crucial to use only full-length 
primers during amplification step. From our experience, it is evident that the presence of 
shorter by-products of oligonucleotide synthesis increases the risk of introducing unwanted 
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mutations, especially short deletions, around the site of mutagenesis, which can make 
selection of the correct clone extremely time-consuming. Therefore, we recommend 
ordering oligonucleotide primers purified by HPLC and/or to purify them by denaturing 
PAGE, as outlined below. 
 
1. Design and order 40 nmoles of MUT-F and MUT-R primers (see Note 4). Resuspend each 
oligonucleotide in 200 μL of sterile water. 
2. Transfer 50 μL of each of the oligonucleotide solutions into separate 1.5 mL microtubes 
and add 25 μL of F-dye. Heat-denature the mixtures for 5 min at 90oC and then place on 
ice. Spin down briefly. 
3. Prepare a 10% denaturing polyacrylamide gel (20 cm x 20 cm) and install it in a vertical 
electrophoresis system with tanks filled with 1x TBE. Rinse the gel wells thoroughly with 
1x TBE to remove diffusing urea right before loading the samples. 
4. Load the content of each tube into a gel well and then run the gel at a constant power of 
15 W until the bromophenol blue (lower dye) has reached approximately 2 cm from the 
bottom edge of the gel (see Note 28). 
5. Gently dismantle the glass plates; the gel should remain attached to only one of the 
plates (see Note 29). 
6. Cover the gel with the saran wrap. 
7. Use a 254 nm hand-held UV lamp in a darkroom to visualize the position of the full-
length oligonucleotide band(s) by UV-shadowing (see Note 30). 
8. Mark the location(s) of the band(s) on the saran wrap or on the reverse side of the glass 
plate using a thin line marker. 
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9. Cut out the corresponding gel band(s) with a sterile scalpel blade (one for each gel 
band(s)). 
10. Put each gel band into a 1.5 mL microtube and centrifuge at 21000 x g in a 
microcentrifuge at room temperature. 
11. Prepare pestle(s) for grinding the gel band(s) by gently melting the end of 1000 μL 
micropipette tip(s) over the flame of laboratory burner or lighter. Wait until the plastic 
cools down and becomes opaque. 
12. Snap-freeze the tube(s) with the gel band(s) in liquid nitrogen, then remove with forceps 
and immediately open lid(s). Incubate at room temperature for approximately 90 
seconds. Using the pestle(s), grind the gel band(s) until homogeneity. 
13. Add 1 mL of DNA extraction buffer to each tube. Incubate overnight at 37oC with shaking 
(see Note 31). 
14. Centrifuge at 21000 x g for 5 min at room temperature and transfer supernatant(s) into 
new microtube(s). 
15. Repeat step 14 to get rid of as much of acrylamide as possible. 
16. Divide supernatant(s) into two microtubes (approximately 450 μL into each tube) and 
precipitate DNA by adding 1 mL of 2-propanol into each tube and incubating overnight at 
-20oC (see Note 32). 
17. Centrifuge at 21000 x g for 15 min at 4oC. Wash the pellets with 70% ethanol and 
centrifuge again. Remove supernatant(s). 
18. Open the tubes and allow pellets to dry for 5 min at room temperature (see Note 22). 
19. Resuspend each pellet in 25 μL of sterile water and combine the contents of both 
precipitation tubes (step 16) so that the total volume is 50 μL. 
20. Measure DNA concentration using a microvolume spectrophotometer (see Note 33). 
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21. Prepare a 250 ng/μL working dilution for each oligonucleotide. 
 
3.2.2 Site-directed mutagenesis 
1. Mix 100 ng of expression plasmid (containing the wild-type exonuclease sequence; see 
section 3.1.4), 10 μL of 5x Phusion HF buffer, 1.5 μL of DMSO, 1 μL of 10 mM dNTP mix, 1 
μL of the purified MUT-F primer (250 ng/μL), 1 μL of the purified MUT-R primer (250 
ng/μL), 0.5 μL of the Phusion High-Fidelity DNA polymerase (2 U/μL) and sterile water to 
50 μL. 
2. Place the mixtures in a thermocycler and run the following PCR program (see Note 34): 
98oC for 3 min (initial denaturation) followed by 35 cycles of denaturation at 98oC for 10 
s, hybridization at 55oC for 30 s, and elongation at 72oC for 60 s per kilobase of insert and 
by a final elongation step at 72°C for 10 min. 
3. Use 5 µL of the mixture for analysis on a standard 1% agarose gel to verify that the 
amplification worked (see Note 35). 
4. Transfer 10 μL of the mixture into a new 1.5 mL microtube and digest the template with 
20 units of DpnI enzyme in a final volume of 20 μL, following manufacturer’s instructions 
(see Note 36). 
5. Transform an aliquot of chemocompetent MH1 cells with 10 μL of the DpnI-treated 
sample, as described in section 3.1.4, step 1. Isolate plasmid clones as described in 
section 3.1.4, steps 2-3.  
6. Digest the purified plasmids using the restriction enzyme recognizing the sequence 
introduced into the MUT-F/MUT-R primers during their design (see Note 4). Using gel 
agarose electrophoresis, compare the restriction pattern with that of the wild-type 
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template digested in the same way; make sure that the patterns differ and that the 
bands with the expected sizes are observed (see Note 37). 
7. Verify insert sequence in selected plasmid(s) using a commercial sequencing service or 
core facility. Make sure that no mutations other than the one introduced during site-
directed mutagenesis occurred. 
 
3.3 Heterologous expression of the exonuclease of interest in bacteria 
1. Transform an aliquot of chemocompetent E. coli BL21-CodonPlus-RIL cells (see Note 9) 
with 100 ng of plasmid DNA as described in section 3.1.4, step 1. Use plasmids encoding 
both wild-type (section 3.1.4) and mutant (section 3.2.2) exonuclease in parallel. Streak 
on LB-kanamycin plates and incubate overnight at 37oC. 
2. In each case, scrap several colonies with an inoculation loop and place them into 300 mL 
Erlenmeyer flasks containing 100 mL of LB medium supplemented with kanamycin and 
chloramphenicol. Incubate overnight at 37oC with shaking. 
3. Dilute 30 mL of the pre-culture from step 2 into 1000 mL of LB medium supplemented 
with kanamycin and chloramphenicol (see Note 38). Incubate until OD600 reaches 0.45-
0.5 and then move the flasks to 18oC (see Note 39); continue shaking the cultures for 30 
minutes to cool them down (see Note 40). 
4. Induce protein expression by adding 1/100th volume of IPTG, so that the final 
concentration is 1 mM and incubate overnight at 18oC with shaking (see Note 39). 
5. Harvest the cells by centrifugation at 4500 x g for 5 min at 4oC. At this stage the pellet 
may be frozen at -20oC for later use. 
 
3.4 Purification of the N-terminally 6xHis-SUMO-tagged exonuclease 
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This section is dedicated to the protocol that should be employed for purification of any 
given 6xHis-SUMO-tagged protein, unless the protein is entirely insoluble following 
heterologous expression. It is based on two rounds of affinity chromatography on a Ni-NTA 
resin, separated by the cleavage of 6xHis-SUMOTag with SUMO protease (Fig. 2a). At the 
end of the first round, the protein of interest equipped with 6xHis-SUMOTag is released 
from the resin during the elution step. In the second round the protein is devoid of 6xHis-
SUMOTag (and thus no longer binds to the column) and predominates in the flow-through 
fraction whereas 6xHis-SUMOTag and SUMO protease (also bearing a 6xHis epitope) remain 
associated with the Ni-NTA resin (Fig. 2a). This experimental setup eliminates contaminating 
proteins, which may potentially co-purify on the nickel resin with the protein of interest. 
Usually, another purification method, such as gel filtration, is then sufficient to purify the 
exonuclease under study to near homogeneity. [Note to publisher: Figure 2 near here] 
 
1. Resuspend cell paste (see section 3.3, step 5) in 10 mL of the lysis buffer, by pipetting 
and/or gently vortexing. Adjust volume to 15 mL using lysis buffer and then divide 
mixture into three 50 mL Falcon tubes. Place the tubes on ice. 
2. Sonicate samples on ice using high power setting and applying 30 seconds on/off cycles 
for 45 minutes (see Note 10). Conditions may vary with the type of sonicator used. 
3. Centrifuge cell debris at 120000 x g for 45 min at 4oC in an ultracentrifuge. 
4. Collect supernatant (approximately 15 mL), corresponding to a total native protein 
extract. Save 20 μL of the extract for SDS-PAGE analysis (Fig. 2b, lane EX). 
5. Install the 1 mL Ni-NTA Superflow Cartridge column on an automated chromatography 
system and equilibrate it with buffer A at a flow rate of 2 mL/min.  
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6. Load the protein extract on the column and collect three 1.5 mL fractions of the flow-
through into the wells of 96-well 2 mL Masterblock plate to assess the efficiency of 
binding of the tagged protein to the nickel resin. Combine fractions and save them for 
SDS-PAGE analysis (Fig. 2b, lane FT1); wash with 20 mL of buffer A (see Note 41). 
7. Wash the column with 10 mL of buffer B and then with 10 mL of buffer A. Elute the 
protein with 10 mL of buffer C (see Note 41). Collect ten 0.5 mL fractions of the eluate 
into the wells of 96-well 2 mL Masterblock plate; save 20 μL of eluate for SDS-PAGE 
analysis (Fig. 2b, lane EL1). 
8. Wash the column with 5 mL of buffer C (see Note 41). 
9. Combine fractions 3-8 of the eluate collected in step 7 (3 mL in total) into a 15 mL Falcon 
tube and add SUMO protease (10 μg/mL) (see Note 42).  
10. Transfer the mixture from step 9 into the appropriate dialysis tubing and dialyze it 
against 2 liters of buffer A overnight at 4oC in order to cleave off the 6xHis-SUMOTag 
from the exonuclease of interest and at the same time to reduce imidazole 
concentration to 10 mM. Save a 20 µL aliquot for SDS-PAGE analysis (Fig. 2b, lane DIAL). 
11. Equilibrate the 1 mL Ni-NTA Superflow Cartridge column (see Note 43) with buffer A and 
load the mixture onto the column using buffer A as the eluent. Collect ten 0.5 mL 
fractions of the flow-through and combine fractions 2-10 together (4.5 mL in total) – 
these constitute the most important sample, as they contain the exonuclease of interest 
separated from the 6xHis-SUMOTag and SUMO protease (Fig. 2b, lane FT2). 
12. Elute the bound proteins (mainly 6xHis-SUMOTag and SUMO protease) with 10 mL of 
buffer D (see Note 41); collect eight 0.5 mL fractions of the eluate into the wells of 96-
well 2 mL Masterblock plate. Combine fractions 3-6 for SDS-PAGE analysis (Fig. 2b, lane 
EL2). 
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13. Analyze the various samples collected during purification by SDS-PAGE. A representative 
gel obtained during purification of A. thaliana DIS3 protein is shown in Fig. 2b. 
14. To further purify the exonuclease, load 1 mL of sample FT2 (step 11) on a SuperdexTM 
75 100/300 GL or SuperdexTM 200 10/300 GL size exclusion column (depending on the 
size of the investigated protein) that had been pre-equilibrated with GF buffer. Collect 
400 µL fractions into the wells of 96-well 2 mL Masterblock plate while monitoring 
absorbance at 215 nm. Transfer fractions corresponding to the most intense peak of the 
chromatogram (Fig. 2a) into 1.5 mL microtubes. 
15. Following analysis by SDS-PAGE, combine fractions that are both the richest and purest 
in exonuclease (see Note 44). Add 0.33 volume of RNase-free glycerol. Mix by gentle 
vortexing and divide the solution into 100 µL aliquots. 
16. Freeze aliquots in liquid nitrogen and store at -80oC (see Note 45). 
 
3.5 Preliminary analysis of the exoribonucleolytic activity using uniformly-labeled RNA 
substrate and thin-layer chromatography 
The most accurate way to assess biochemical features of the purified exonuclease (e.g., 
directionality, processivity, etc.) is by using the methods described in sections 3.7 to 3.9. 
However, these methods are effort/time-consuming and it is often useful to perform a 
simpler analysis beforehand, to tentatively demonstrate that the wild-type protein is active 
whereas its mutated counterpart is not (or has an activity that is significantly reduced). To 
this end, we use an internally-labeled RNA substrate obtained by in vitro transcription in the 
presence of [-32P]-UTP. Irrespective of enzyme directionality, exonuclease-mediated 
degradation of such RNA will release [-32P]-UMP which is easily detected by TLC. A detailed 
protocol is provided below. 
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3.5.1 Preparation of the uniformly-labeled RNA substrate 
1. In a laboratory suitable for handling radiomaterials, mix 3 µL of 10x RNAPol Reaction 
Buffer, 3 µL of 100 mM DTT, 3 µL of NTP Mix, 0.5 µg of gel-purified, linearized plasmid 
(see Note 11), 1.5 µL of RiboLockTM RNase Inhibitor, 3 µL of [α-32P]-UTP, 1.5 µL of 50 U/µL 
T7 (or 20 U/µL SP6)  RNA polymerase, and sterile RNase-free water to 30 µL. Incubate at 
37oC for 90 min and then add 0.75 µL of T7 (or SP6) RNA polymerase. Incubate at 37oC 
for 30 min. 
2. Inactivate the enzyme by incubating the mixture at 90oC for 5 min. Place the tube on ice 
for 30 seconds and then spin down briefly. 
3. Add 30 µL of phenol/chloroform and vortex for 30 seconds. Centrifuge at 21000 x g for 5 
min at room temperature and collect the upper aqueous phase. 
4. Pack a Spin Module with Sephacryl S-200 resin equilibrated in TE buffer. Load sample in 
the Spin Module and centrifuge at 1000 x g for 3 min.  
5. Estimate the radioactivity in the Spin Module eluate with a hand-held radioactivity 
detector. 
6. Use RNA dilution buffer to prepare an aliquot of labeled RNA representing approximately 
1500-2000 cps of radioactivity in a final volume of 100 µL. 
 
3.5.2 Preliminary exoribonuclease activity assay and TLC analysis 
1. Prepare 1.5 mL microtubes, each containing 0.5 µL of 0.5 M EDTA (see Note 46). 
2. In a 1.5 mL microtube, combine 10 μL of the appropriate reaction buffer (see Note 12) 
and 5 μL of the protein solution in GF buffer, purified as described in section 3.4 (in our 
case, approximately 2 pmol of protein) (see Note 47). Place on ice. 
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3. Add 5 μL of the labeled RNA oligonucleotide solution (section 3.5.1, step 6), mix by 
pipetting, and transfer 5 μL of the mixture into the first tube containing EDTA. Freeze this 
t0 sample in liquid nitrogen (see Note 48). Incubate the remainder of the reaction mixture 
at 37oC (see Note 49). 
4. At desired reaction times, remove 5 μL reaction aliquots and mix them with EDTA in the 
preset tubes (step 1).  Freeze each quenched aliquot in liquid nitrogen (see Note 48). 
5. After collecting the last sample, take the tubes one by one out of the liquid nitrogen. 
Open tubes to avoid popping due to the rapid change of temperature and leave them 
open at room temperature for 2 min. 
6. Spot 1 µL aliquots (equal to approximately 3-5 cps of radioactivity) from each of the 
collected samples onto the PEI Cellulose TLC plate (samples taken at consecutive time 
points for each reaction condition should be analyzed side by side, starting from t0; Fig. 
3). The leftmost and rightmost spots should not be closer than 1 cm to the edges of the 
TLC plate (Fig. 3). 
7. Wait until all spots are completely dry (see Note 50). 
8. Develop the plate by evenly placing the bottom edge of the TLC plate in a tray containing 
developing solution (see Note 51). Maintain the plate vertical during development and 
allow the solvent front to migrate up to ~2 cm from the top of the TLC plate. 
9. Allow the developing solution to evaporate completely from the plate (see Note 52). 
Cover plate with saran-wrap and expose it to a phosphorimaging screen overnight. 
10. Scan the screen with a phosphorimager. A representative example of TLC image 
obtained upon analysis of different variants of the human DIS3 protein is shown in Fig. 3 
(see Note 53). [Note to Publisher: Figure 3 near here]. 
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3.6 Purification of the synthetic RNA oligonucleotide substrate 
Analysis of exonuclease activity requires relatively short (20-100 nt) RNA oligonucleotides 
labeled in different ways that are used as substrates in the assays. Prior to labeling, it is best 
to PAGE-purify synthetic RNA oligonucleotides as described below. 
1. Order 200 nmoles of the RNA oligonucleotide to be used as substrate in the enzymatic 
assays (see Note 54) from a commercial source. Resuspend in 100 μL of sterile RNase-
free water. 
2. Mix 25 μL of the oligonucleotide solution with 25 μL of F-dye (store the remainder of 
RNA oligonucleotide solution at -80oC in 25 μL aliquots). 
3. Incubate mixture at 90oC for 5 min, place on ice, and then spin down briefly. 
4. Proceed as described in section 3.2.1, steps 3 to 12. 
5. Add 650 µL of RNA elution buffer and 300 µL of phenol/chloroform to the homogenized 
gel piece. Incubate overnight at room temperature on a rotating wheel. 
6. Centrifuge the acrylamide at 21000 x g for 3 min at room temperature and carefully 
transfer the upper aqueous phase into a new microtube. 
7. Precipitate purified RNA oligonucleotide by adding 1 mL of 2-propanol and incubating 
overnight at -20oC. 
8. Centrifuge at 21000 x g for 15 minutes at 4oC and remove supernatant. Wash the pellet 
with 80% ethanol and spin down again. 
9. Open the tube and allow pellet to dry for 5 minutes at room temperature (see Note 22). 
10. Dissolve the pellet in 25 μL of sterile water and determine RNA concentration by 
measuring absorbance at 260 nm with a microvolume spectrophotometer. 
11. Prepare a working dilution of the RNA oligonucleotide (150 pmol/μL) with RNase-free 
water. 
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3.7 Preparation of synthetic RNA oligonucleotide substrates labeled in different ways 
In this section, we describe the preparation of the various RNA substrates required for 
detailed analysis of ribonuclease features.  Only the combination of assays performed with 
substrates labeled in different manners will provide the researcher with unambiguous 
information about the directionality of the exonuclease, the presence (or lack) of 
accompanying endonuclease activity, processivity, length/distribution of the degradation 
products, and specificity towards single-stranded versus structured substrates. 
 
3.7.1 Labeling of the synthetic RNA oligonucleotide substrate at the 5’-end and purification 
of the labeled substrate 
1. In a 32P-dedicated laboratory, mix 5 µL of sterile RNase-free water, 1 µL of 10x T4 PNK 
buffer, 1 µL of T4 PNK enzyme, 1 µL of purified RNA oligonucleotide (section 3.6, step 
11), and 2 µL of [γ-32P]ATP. 
2. Incubate for 60 min at 37oC and then for 5 min at 90oC. Place the tube on ice for 30 
seconds and then spin down briefly. 
3. Add 20 µl of phenol/chloroform, vortex for 30 seconds, and centrifuge at 21000 x g for 5 
min at room temperature. 
4. Transfer aqueous upper phase to a new tube and add 20 µL of F-dye. Incubate for 5 
minutes at 90oC and then place on ice. 
5. Spin down briefly and load the entire mixture into the flushed well of a preparative 10% 
denaturing polyacrylamide gel (see section 3.2.1). Run the gel at a constant power of 15 
W until the bromophenol blue (lower dye) is approximately 5 cm from the bottom edge 
of the gel. 
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6. Gently dismantle the glass plates (the gel should remain attached to only one of the 
plates). Cover the gel with saran wrap and place it behind a shielding Plexiglas screen 
efficiently stopping beta-radiation emitted by 32P. 
7. In a darkroom, expose the gel to an autoradiography film (mark the position of the film 
on the gel with a thick permanent marker by drawing several horizontal or diagonal lines 
crossing the border of the film and the gel). After exposure, develop the film (using a 
dedicated instrument or manual transfers into developing and fixating bathes).  
8. Behind a Plexiglas screen, align the gel with the film utilizing the guide marks and excise 
the slowest migrating (usually most intense) band from the gel using a nuclease-free 
scalpel blade.  
9. Proceed as described in section 3.2.1 steps 10-12 and then section 3.6 steps 5-6. 
10. Precipitate purified labeled RNA oligonucleotide by adding 2 µL of RNase-free glycogen 
(20 mg/mL) and 1 mL of 2-propanol and by incubating overnight at -80oC. Centrifuge at 
21000 x g for 15 minutes at 4oC and remove supernatant. 
11. Proceed as described in section 3.6 steps 8-9. 
12. Dissolve the pellet in 100 μL of sterile water and estimate sample radioactivity with a 
hand-held detector. 
13. Analyze an aliquot of the purified labeled RNA oligonucleotide (equal to approximately 
20 cps) on a small (10 x 8 cm) 10% denaturing polyacrylamide gel. After electrophoresis, 
remove plates and place the gel on a piece of developed autoradiography film (see Note 
55), cover it with saran-wrap and expose it to a phosphorimaging screen overnight.  
Ensure that no RNA degradation occurred during purification. 
 
3.7.2 Labeling of the synthetic RNA oligonucleotide substrate at the 3’-end 
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1. To prepare [5’-32P]cytidine 3’,5’-bis(phosphate) (pCp) (see Note 56), mix 3 µL of 3.75 mM 
3’-CMP, 2.5 µL of sterile RNase-free water, 1 µL of 10x T4 PNK buffer, 1 µL of T4 PNK 
enzyme, and 2.5 µL of [γ-32P]ATP. Incubate overnight at 37oC. 
2. Spin down briefly and extract the mixture with 20 µL of phenol/chloroform by vortexing 
for 30 seconds. Centrifuge at 21000 x g for 5 minutes at room temperature and transfer 
the aqueous upper phase containing labeled pCp into a new microtube. 
3. Mix 3 µL of sterile RNase-free water, 1 µL of purified RNA oligonucleotide (150 pmol/µL; 
section 3.6.2, step 11), 2 µL of 10x reaction buffer for T4 RNA ligase I, 2 µL of DMSO, 2 µL 
of 1 mM ATP, 2 µL of 100 mM DTT, 1 µL of RiboLock RNase Inhibitor, 2 µL of T4 RNA 
ligase I and 5 µL of [5’-32P]pCp from step 2 (see Note 56). Incubate for 2 hours at 37oC. 
4. Proceed as described in section 3.7.1 steps 4-13 to purify and check the 3’-labeled 
substrate. 
 
3.7.3 Preparation of the labeled circular RNA oligonucleotide 
1. Mix 2 µL of sterile RNase-free water, 2 µL of 500 mM Tris-HCl, pH 8, 4 µL of 50 mM 
MgCl2, 2 µL of 100 mM DTT, 1 µL of purified RNA oligonucleotide (150 pmol/µL; section 
3.6.2, step 11), 3 µL of 100 µM ATP, 3 µL of [γ-32P]ATP, 1 µL of RiboLock RNase Inhibitor, 
1 µL of T4 PNK, and 1 µL of T4 RNA ligase I. Incubate for 2 h at 37oC. 
2. Proceed as described in section 3.7.1 steps 4-13 to purify and check the labeled, 
circularized substrate (see Note 57). 
3.7.4 Preparation of the partially double-stranded RNA substrate (see Note 58) 
1. Prepare the annealing reaction by mixing 400 pmol of purified RNA oligonucleotide 1 
with 600 pmol of the purified RNA oligonucleotide 2 and an aliquot of 32P-labeled RNA 
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oligonucleotide 1 (~3000 cps). Adjust to 500 µL with RNA dilution buffer to reach a 
concentration of 0.8 pmol/μL. 
2. Incubate for 7 minutes at 90oC in a thermoblock. Switch off thermoblock and wait until it 
cools down to room temperature. 
3. Mix 5 µL of the annealing reaction with 5 µL of the native gel loading dye. 
4. Prepare a control sample containing approximately the same amount of 32P-labeled RNA 
oligonucleotide 1 (~3000 cps). 
5. Load both samples on a small (10 x 8 cm) 15% native polyacrylamide gel and run gel for 
30 min at 30 V/cm. 
6. Disassemble the gel cassette, place the gel on a piece of developed autoradiography film 
(see Note 55), cover it with saran-wrap and expose it to a phosphorimaging screen 
overnight. 
7. Scan screen with a phosphorimager to ensure proper formation of the duplex substrate 
(see Note 59). 
 
3.8 Gel-based assay for exoribonuclease activity using 5’-labeled RNA oligonucleotide 
substrate 
In this section we detail exoribonucleolytic degradation analysis based on the separation of 
the decay products in a denaturing polyacrylamide gel. Although we use the A. thaliana DIS3 
protein (which degrades its substrates exonucleolytically in the 3’-5’ direction) as an example 
(Fig. 4a), the same assay may be employed to study 5’-3’ exoribonucleases. In this latter 
case, however, the final degradation product will be a single 32P-labeled nucleotide which 
may be better detected by TLC than by PAGE. Here, we only detail the assay with 5’-labeled 
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substrate (section 3.7.1) but the same protocol/rules are valid for the other substrates 
(sections 3.7.2, 3.7.3, and 3.7.4).  
 
1. Prepare a 20% denaturing polyacrylamide gel using 1 mm-thick spacers and comb (see 
Note 15). 
2. Prepare a substrate master mix containing 800 pmol of unlabeled RNA oligonucleotide 
(section 3.6) and ~1500 cps of its 5’-labeled counterpart (section 3.7.1). Adjust to 100 µL 
with RNA dilution buffer to obtain a RNA concentration of 8 pmol/μL (see Note 60). 
3. Prepare 1.5 mL microtubes, each containing 5 µL of F-dye (see Note 46). 
4. In a 1.5 mL microtube, mix 10 μL of the appropriate reaction buffer (see Note 12) with 5 
μL of thawed solution of purified protein (section 3.4, step 16; e.g., ~ 2 pmol of DIS3 
protein) (see Note 47). Place on ice. 
5. Add 5 μL (40 pmol) of substrate master mix (step 2), mix by pipetting, and transfer 5 μL 
into the first tube containing F-dye (t0 sample) (see Note 48). Freeze this sample in liquid 
nitrogen. Incubate the remainder of the reaction mixture at 37oC (see Note 49). 
6. At desired reaction times, remove 5 μL reaction aliquots and mix them with F-dye in the 
preset tubes (step 3). Freeze each quenched aliquot in liquid nitrogen (see Note 48) 
7. After collecting the last sample, take the tubes one by one out of the liquid nitrogen. 
Open tubes to avoid popping due to the rapid change of temperature and leave them 
open at room temperature for 2 min. 
8. To denature RNA, incubate tubes at 90oC for 5 min, place on ice, and then spin down 
briefly. 
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9. Analyze one-half (5 μL) of each sample by denaturing 20% PAGE (32 x 26 cm gel) (see 
Note 15). Perform electrophoresis at 30 W until bromophenol blue (lower dye) reaches ~ 
5 cm from the bottom edge of the gel.  
10. Disassemble the gel cassette, place the gel on a piece of developed autoradiography film 
(see Note 55), taking care not to tear it, cover it with saran-wrap and expose to a 
phosphorimager screen overnight. Scan the screen with a phosphorimager. 
 
A representative example of the analysis performed for A. thaliana DIS3 protein is 
presented in Fig. 4a. Control experiments with RNA substrates labeled in different ways as 
well as with the isolated PIN domain of DIS3 (displaying endoribonucleolytic activity) are 
presented in Fig. 4b. [Note to Publisher: Figure 4 near here]. 
 
3.9 XRN1 5’-3’ exoribonuclease activity assay employing RNA oligonucleotide substrates 
with different 5’-end phosphorylation status and labeled at the 3’-end with a fluorescent 
dye 
To assess the succeptibility of 5’-3’ exoribonucleases to the phosphorylation status in vitro, 
one requires RNA substrates which have the same nucleotide sequence but bear different 
moieties at their 5’-ends. Uniformly labeled substrates bearing a 5’-triphosphate (5’-PPP) 
may be obtained by in vitro transcription performed in the presence of radioactive UTP 
(section 3.5.1).  Substrates equipped with a monophosphate (5’-P), hydroxyl group (5’-OH) 
or methylated cap analog (5’-m7Gppp) may be synthesized with the same protocol, by 
adding GMP, guanosine, or cap analog, respectively, to the reaction mixture in a molar 
excess over other ribonucleoside triphosphates (NTPs). Alternatively, they may be purchased 
as  synthetic oligoribonucleotides together with a fluorescent dye, such as fluorescein (FAM), 
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at their 3’-end. Note that such fluoro-labeled oligonucleotides may also replace 32P-labeled 
substrates in a number of the assays presented herein, thereby offering grater safety 
(handling radiochemicals requires great care) and longer substrate life (half-life of 32P is 14.3 
days). However, fluorescent dyes are bulky, hydrophobic moieties and sometimes interfere 
with enzymatic activities. The protocol presented below utilizes commercially available XRN1 
enzyme and different fluorescently labeled oligoribonucleotides. 
 
1. Prepare a 20% denaturing polyacrylamide gel using 1 mm-thick spacers and a comb (see 
Note 18). 
2. Prepare a working solution of each fluorescently labeled RNA substrate by diluting 1 µL 
of the 200 µM stock to 1 µM final concentration with sterile RNase-free water (see Note 
47). 
3. Prepare a working solution of the protein by diluting XRN1 in 1x NEBuffer 3 to a 
concentration of 0.025 U/µL (see Note 47). 
4. Prepare 1.5 mL microtubes, each containing 5 µL of F-dye (see Note 46). 
5. In a 1.5 mL microtube, mix 2 µL of NEBuffer 3 (see Note 12), 1 µL of protein solution 
(step 3), 1 µL of the RiboLockTM RNase Inhibitor, and sterile RNase-free water to 15 µL. 
Place on ice. 
6. Add 5 μL of the RNA working solution (step 2), mix by pipetting, and transfer 5 μL into 
the first tube containing F-dye (t0 sample) (see Note 48). Freeze this sample in liquid 
nitrogen. Incubate the remainder of the reaction mixture at 37oC (see Note 49). 
7. Proceed as described in section 3.8, steps 6-10, albeit using a power of 25 W during 
electrophoresis and a migration of bromophenol blue to ~3 cm from the bottom edge of 
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the gel. A representative experiment is shown in Fig. 5. [Note to Publisher: Figure 5 near 
here]. 
4 Notes 
1. The insert may be obtained by PCR amplification (using SLIC-F and SLIC- primers) of cDNA 
isolated/prepared from the appropriate cells. If only small amounts of insert are 
obtained, it is highly advisable to pre-clone it into the pCRTM-Blunt II-Topo® vector (part 
of the Zero Blunt® Topo® PCR cloning kit from Invitrogen) before attempting to clone it 
into the pET28M-6xHis-SUMOTag vector (usually greatly increases the probability of 
successful cloning). The insert might be sequenced at this stage using standard M13 
forward and reverse primers (as well as other self-designed primers) to exclude the 
presence of unwanted mutations. 
2. 10 mM dNTP mix might be prepared from solutions of individual deoxyribonucleoside 
triphosphates or purchased as ready-to-use mix. 
3. Prepare under the fume hood by mixing 25 mL of phenol solution saturated with 10 mM 
Tris-HCl pH 8.0, 24 mL of chloroform, and 1 mL of isoamyl alcohol in a 50 mL Falcon tube. 
Wait until phases are clearly separated (the bottom phase is the organic phase that is 
added to the samples). Wrap the tube with aluminium foil to protect from light and store 
at 4°C. Do not use once the color of the organic phase has turned yellow or pink, an 
indication of phenol oxidation. Always wear safety glasses, gloves and a laboratory coat 
when working with solutions containing phenol to avoid skin/eye burns. 
4. The site-directed mutagenesis primers (MUT-F/MUT-R) should be designed to introduce 
an inactivating mutation of one (or more) of the conserved amino acids in the catalytic 
center of the examined exonuclease.  
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5. Always wear a mask and gloves when weighing acrylamide powder and gloves when 
working with unpolymerized acrylamide solution, because it is a strong neurotoxin. 
6. After addition of APS, the polymerization is able to take place, even in the absence of 
TEMED, which only catalyzes this reaction; the polymerization speed depends on the 
acrylamide percentage and the temperature; when pouring 10-20% polyacrylamide gels 
at high ambient temperature, it is advisable to store the solution of acrylamide with 
added APS at 4oC for a short time in order to avoid its uncontrolled polymerization; 
however, the solution cannot be kept for too long in a refrigerator, since it will cause 
precipitation of urea. If this happens, it can be counteracted by heating the mixture in a 
waterbath set at 37oC until urea is dissolved again. Afterwards, TEMED has to be added 
and the gel must be poured immediately.  
7. Whenever air bubbles start to appear while pouring vertical polyacrylamide gel, one may 
easily get rid of them by leaning the gel cassette into one direction, waiting until they 
migrate to the upper edge of the polyacrylamide solution poured between the glass 
plates and knocking the front glass plate with finger knuckles until they disappear. 
8. Since the volume of the primer solution mixed with F-dye to be loaded into the wells of 
the polyacrylamide gel is quite high, it is advisable to use a comb with wide teeth (1.5-2 
cm). 
9. We routinely use E. coli BL21-CodonPlus-RIL strain for heterologous expression of 
eukaryotic proteins, although other appropriate expression strains may also be used. 
10. An alternative method for efficient disruption of bacterial cells may be employed if 
preferred, such as a French press or a microfluidizer. 
11. Such a plasmid is easily constructed by subcloning a 100-500 nt-long DNA fragment 
derived from virtually any open reading frame into a plasmid containing either a T7 or 
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SP6 transcription start site upstream from the cloning site and a single-cut restriction site 
downstream. The restriction site is subsequently used to linearize the plasmid.  
12. There are no universal buffer conditions for every exonuclease; we present the buffer 
composition that worked successfully in our hands for DIS3 protein homologs from 
different species as an example; reaction conditions, including reaction buffer, 
temperature and time of incubation must be optimized by performing several 
consecutive preliminary assays. Buffer parameters that may be tested are buffering 
agent (Tris, Hepes, MOPS, etc.), monovalent salt (NaCl or KCl), salt concentration, 
divalent cation cofactor (Mg2+, Mn2+, Zn2+), concentration of the metal cofactor, pH, 
presence of the reducing agent, BSA, glycerol, etc. 
13. We use synthetic ss17-Ax RNA as RNA oligonucleotide 1, where ss17 represents a 17 nt-
long random sequence (5’-CCCCACCACCAUCACUU-3’) and Ax corresponds to an oligo(A) 
tail of various length, ranging from 2 to 34 adenosines. 
14. We use 17 nt-long compl RNA (5’-AAGUGAUGGUGGUGGGG-3’) as RNA oligonucleotide 
2. It is fully complementary to the 5’ part of ss17-Ax RNA oligonucleotide 1 (see Note 13). 
15. The comb and size of the gel depends on number of samples/conditions tested in a 
single assay. 
16. Oligonucleotide sequence may be modified according to preferences. 
17. PAGE purification may be performed as described in section 3.6. 
18. Resolution is significantly better when utilizing fluorescently-labeled RNA 
oligonucleotides, when compared to the substrates labeled with radioisotopes. Shorter 
gels (we use 20 cm x 5 cm plates and 50-well comb) may be used in such cases. 
19. These PCR conditions have worked satisfactorily for most inserts. However, if small 
amounts of the amplicon are obtained or unspecific PCR products are evident, one may 
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want to try standard troubleshooting strategies, such as annealing temperature gradient, 
attempting “touch-down” PCR protocol (where the annealing temperature is set 
relatively high during initial cycles of amplification and is decreased in increments in 
every subsequent cycle), optimizing magnesium, primer, or DMSO concentration. 
Ordering new primers with extended region complementary to the insert may also be 
taken into consideration. 
20. Although 15 s of elongation during PCR amplification with Phusion polymerase might be 
sufficient for some plasmid templates, we find that extending this step to 30 s increases 
the amounts of the desired product in numerous cases. 
21. Wear gloves when working with ethidium bromide solutions, since it is a strong 
mutagen. 
22. Do not dry the pellet for too long; once overdried, it might be difficult to dissolve. 
23. The preparative agarose gel can be also stained with ethidium bromide, however we 
prefer to use GelGreenTM dye since its fluorescent signal might be excited with blue light 
instead of UV, which reduces the risk of introducing mutations during excision of the gel 
fragments containing bands of interest. 
24. In our opinion this method of estimating DNA concentration following column-based 
purification of DNA gives more accurate results than a spectrophotometer as column kit 
contaminants often absorb at 260 nm. 
25. This annealing step might be also performed at 37oC for 30 minutes. 
26. The mixture might be stored at -20oC for later use. 
27. Other E. coli strains dedicated to cloning, such as DH5, may also be used. The strain 
must have an active deoxyadenosine methylase (dam+) for purposes of the site-directed 
mutagenesis (see Note 36). If transformation efficiency is low, electroporation of 
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appropriate electro-competent cells may be performed provided that the SLIC reaction 
mixture has been subjected to desalting by ethanol precipitation or dialysis. 
28. On 10% denaturing polyacrylamide gels, the upper (xylene cyanol) and bottom 
(bromophenol blue) dyes migrate, respectively, as ~55 nt- and ~12 nt-long single-
stranded DNA. Conditions provided in the protocol are usually sufficient to resolve the 
full-length primers (50-60 nt) from shorter by-products. 
29. To increase the probability that the gel remains attached to only one glass plate while 
disassembling the gel cassette, one of the glass plates may be wiped with Rain-X before 
pouring the gel. 
30. Usually, signal for the full-length oligonucleotide is strong enough to be distinguished 
from ones of by-products. Nonetheless, UV shadows can be increased by placing a TLC 
plate or an X-ray intensifying screen under the gel. 
31. Seal the tubes with parafilm to prevent them from accidental opening and stick them in 
horizontal position to the platform of an incubation shaker with adhesive tape. 
32. Since the elution buffer contains ammonium acetate at high concentration, addition of 
salt during precipitation step is not necessary. 
33. A regular spectrophotometer may also be used, although with a microvolume instrument 
a small sample aliquot is used for measurement and then discarded, thereby avoiding 
risk of contaminations. 
34. These amplification conditions work in most cases, although optimization may be 
considered if the full-length product is barely visible by agarose gel electrophoresis. 
35. A distinct band of the size corresponding to the full-length plasmid should be observed; if 
this is not the case, the products of amplification may be processed further, but from our 
experience it is clear that the probability of successful mutagenesis is much lower; 
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however, there were cases when the mutagenesis went off well even if a smear of 
heterogeneous products was observed following amplification. 
36. This step is essential in order to get rid of the template plasmid containing wild-type 
insert; otherwise, identification of the clones bearing mutated plasmid in subsequent 
steps of the procedure might be severely hampered by strong background. DpnI is a 
methylation-sensitive restriction endonuclease, which means that it will digest only the 
original, un-mutated template, which contains methylated adenines within GATC motifs 
(provided that the plasmid was isolated from dam+ E. coli strain), but not the products of 
mutagenesis, synthesized during PCR. 
37. Verification of the presence of the restriction site introduced by the primers for 
mutagenesis can be quite problematic if the site is only 4 nucleotides long; in such case, 
it is recommended to amplify the insert (for instance using SLIC-F/SLIC-R pair of primers) 
from step 1 in section 3.1.1 (or even its fragment encompassing the site of mutagenesis) 
by PCR and then subject it to digestion with the 4-cutter enzyme. A similar control should 
be performed with un-mutated plasmid. 
38. We prefer LB Broth Base from Invitrogen to prepare medium for the bacterial culture 
used for protein expression. 
39. Performing induction of protein expression at a lower than physiological temperature 
reduces the risk of the formation of insoluble protein aggregates called inclusion bodies. 
In such cases, decreasing IPTG concentration and/or duration of induction may help. If 
the problem persists, one may use autoinduction media (23). 
40. Small samples of the culture may be collected before and after induction and analyzed 
by SDS-PAGE to determine if induction of protein expression worked well (either by 
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direct staining of the gel with Coomassie Brilliant Blue or by performing western-blot 
detection of the protein using anti-6xHis antibodies). See -/+I samples in Fig. 2b. 
41. We utilize an ÄKTApurifier FPLC system since it allows convenient, semi-automated 
purification of the protein. However, if the user does not have access to such an 
equipment, the purification can be done entirely manually at 4oC by batch incubation of 
the native protein extract with a Ni-NTA agarose slurry, followed by the transfer of the 
resin with the bound proteins in an empty, gravity-flow chromatography column. 
42. SUMO protease may be obtained from commercial sources. However, to reduce the 
costs of purification, we routinely prepare a home-made version of the enzyme with 
6xHis-tag. 
43. The column from section 3.4, step 6 can be reused here. 
44. If the protein purity is not satisfactory at this stage, an additional purification method 
might be employed, such as ion-exchange chromatography. 
45. Protein concentration may be estimated from gel band intensity (and densitometry) 
after running an aliquot of purified exonuclease on a SDS-PAGE gel alongside with 
different BSA or lysozyme dilutions of known concentrations (containing protein 
amounts ranging from 0.125 to 10 µg). Alternatively, a spectroscopic method (e.g., 
Bradford assay) may be used, albeit with a lower accuracy. 
46. Total number of microtubes will depend on how many different reaction conditions and 
time points will be analyzed per assay. 
47. The optimal molar protein:substrate ratio depends on the exoribonuclease under study. 
The amounts of the enzymes and RNA provided here proved adequate for a number of 
specific proteins and substrates but may not suit all cases. 
 
 
48 
 
48. When working with multiple samples in a single assay, it is most convenient to start each 
reaction separately by addition of the RNA substrate in time intervals (not shorter than 
20 seconds between two consecutive samples, to have time for transferring the aliquot 
of the sample into the tube with stopping EDTA solution). 
49. Temperature is another reaction parameter which must be optimized for each particular 
exonuclease. 
50. If the phosphorimager used for TLC analysis is not sufficiently sensitive, steps 6-7 may be 
repeated several time to increase the amount of radioactivity per spot, provided that no 
more than 1 µL of sample is applied per spot every time and that all spots are allowed to 
dry completely before another sample application. 
51. It is not absolutely necessary to use a dedicated chromatography chamber. Instead, one 
may use a container (i.e. beaker or jar) tightly sealed with parafilm or aluminum foil to 
ensure saturation of the inside atmosphere with the developing solution. 
52. This can be accelerated by using a hair-dryer or other type of blower dryer, set at low 
heating temperature. 
53. If the activity of the exonuclease mutant is only diminished (as for hDIS3 A507P in Fig. 3),  
the difference with wild-type activity may be better visualized at early than late time 
points and the reaction time course may need to be adjusted accordingly.  
54. There is no universal RNA sequence to probe exonuclease activity and it is advisable to 
test several substrates including, for example, generic ones (with random sequence), 
polyribonucleotides (i.e. A20 or U20; particularly for exonucleases which are predicted to 
display some sequence preferences, such as deadenylases), or ones with mixed features 
(we routinely use single-stranded RNAs composed of 17-mer generic sequence followed 
by oligo(A) tails of different lengths, ranging from 2 nt to 34 nt).  
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55. Using this method, it is not necessary to place the gel on the Whatman 3 mm paper and 
to dry it completely in a vacuum dryer before the exposure. 
56. Labeled pCp may be purchased instead of being synthesized with the method that we 
describe. However, as it is not used as frequently as other radiochemicals, such as for 
instance [γ-32P]-ATP, we often prepare it ourselves as presented herein. It should be 
noted, however, that the efficiency of 3’ RNA labeling is significantly higher when using 
commercial rather than home-made radiolabeled pCp. 
57. Circularized RNA oligonucleotide migrates slightly slower in denaturing polyacrylamide 
gels than the linear oligoribonucleotide of the same sequence. In practice, linear and 
circular RNA substrates are often prepared in parallel and purified on the same gel.  In 
this case, it is advisable to use a 20% (instead of 10%) polyacrylamide gel to better 
visualize migration differences (this also facilitate separation of the circularized products 
from traces of linear substrates).  
58. We include description of the partially double-stranded RNA substrate preparation, as 
some exoribonucleases (including DIS3) are active towards such substrates. Other 
enzymes may even prefer structured RNA molecules more than single-stranded 
substrates. 
59. There must be no visible traces of the single-stranded substrate in the lane 
corresponding to the sample which was subjected to annealing; if this is the case, the 
amount of the RNA oligonucleotide 2 present in the annealing reaction should be 
increased. 
60. This will give a 1:20 molar ratio of protein:substrate which we found to be optimal for 
assays employing DIS3 proteins and single-stranded substrates. We emphasize that this 
 
 
50 
 
ratio may not be appropriate for other exoribonucleases and should be optimized 
experimentally. 
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Figure legends 
Figure 1: Possible degradation patterns of RNA oligonucleotide substrates labeled in 
different ways as a tool for determination of exoribonuclease directionality and 
discriminating between exonucleolytic and endonucleolytic activities. (a) 5’-3’ and (b) 3’-5’ 
exoribonucleases may be distinguished based on products obtained with linear 5’- and 3’-
end labeled substrates, unless in both cases mononucleotides are produced, which requires 
an additional experiment employing a special substrate (e). Enzymes belonging to these two 
groups do not have the ability to cleave circularized RNA molecules. Indeed, it is a unique 
feature of endoribonucleases, which may cleave RNA at a specific site (c) or cut it without 
any particular substrate specificity (d).  
 
Figure 2: Purification of the N-terminally 6xHis-SUMO-tagged exonuclease following its 
heterologous overexpression in bacteria. (a) Scheme of the purification procedure. (b) A 
representative SDS-PAGE gel illustrating purification of the full-length Arabidopsis thaliana 
DIS3 (AtDIS3) protein. Samples were collected at various stages of purification, as described 
in the main text. A strong band at the expected size in the +I sample (following IPTG 
induction) indicates that protein expression was successful. The same band (although 
considerably weaker) was also present in lane EX, meaning that the protein is soluble, at 
least partially. The 6xHis-SUMO-tagged exonuclease binds to the Ni-NTA resin and is not 
present in flow-through (lane FT1) but is eluted in presence of high concentration of 
imidazole (lane EL1). Following removal of the 6xHis-SUMO epitope by the SUMO protease, 
the molecular mass of the protein is reduced (lane DIAL). Without 6xHis-SUMOTag, the 
exonuclease no longer binds to the Ni-NTA resin and is retrieved in flow-through (lane FT2) 
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rather than in fractions eluted in the presence of high concentration of imidazole (lane EL2). 
The latter fractions contain free 6xHis-SUMOTag as well as SUMO protease. 
 
Figure 3: TLC analysis of exoribonucleolytic activity. Recombinant wild-type (WT) and D487N 
and A507P mutants of human DIS3 (hDIS3) were analyzed.  
 
Figure 4: Gel-based analysis of AtDIS3 nucleolytic activities. Positions of bands corresponding 
to starting substrates are indicated by arrows. (a) AtDIS3 displays 3’-5’ exoribonucleolytic 
activity. Recombinant WT and D489N catalytic mutant of AtDIS3 were analyzed. Final 
degradation products (4-5-nt) are observed only in the case of WT AtDIS3. (b) The N-terminal 
PIN domain of AtDIS3 has an endoribonucleolytic activity. The pattern of degradation 
products observed in the case of 5’-end labeled substrate is entirely different from that 
observed in pannel a. Moreover, ladders of products generated during degradation of 5’-end 
labeled and 3’-end labeled linear substrates, as well as the ability to linearize circular RNA 
molecule (which is further degraded by the PIN WT variant) are evidence of “degradative” 
endoribonucleolytic activity (Fig. 1).  
Figure 5: Gel-based assay demonstrating dependence of XRN1 5’-3’ exoribonuclease activity 
on the status of the substrate 5’-end. Four RNA oligonucleotides having the same nucleotide 
sequence, but differing by the moiety present at the 5’-terminus (monophosphate, 
triphosphate, hydroxyl or methylated cap) and labeled at the 3’-end with FAM were 
incubated with or without XRN1 protein. Positions of the substrates and short 
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oligoribonucleotide degradation products are marked with different arrows. Only 5’-
monophosphorylated substrate is degraded efficiently by XRN1. 
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Figure 1. 
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Figure 2. 
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Figure 5. 
 
